Skip to main content
. 2024 Sep 18;11:1326333. doi: 10.3389/fmed.2024.1326333

Table 3.

Magnitude of adverse obstetrical and perinatal outcomes of the study participant at WCSH, Northeast Ethiopia, 2023.

Adverse obstetrical outcome variables Admission status of mothers Total
Women with preeclampsia Normotensive women
N (%) N (%) N (%)
Adverse obstetrical outcomes Yes 31 (22.10) 19 (6.80) 50 (11.90)
No 109 (77.90) 261 (93.20) 370 (88.10)
Postpartum hemorrhage Yes 11 (7.90) 9 (3.2) 20 (4.76)
No 129 (92.10) 271 (96.8) 400 (95.24)
Antepartum hemorrhage Yes 8 (5.70) 6 (2.10) 14 (3.33)
No 132 (94.30) 274 (97.90) 406 (96.67)
Pulmonary edema Yes 1 (0.70) 0 (0.00) 1 (0.24)
No 139 (99.30) 280 (100.00) 419 (99.76)
Maternal death Yes 1 (0.70) 0 (0.00) 1 (0.24)
No 139 (99.30) 280 (100.00) 419 (99.76)
Blood transfusion Yes 13 (9.30) 8 (2.9) 21 (5)
No 127 (90.70) 272 (97.10) 399 (95)
Composite adverse perinatal outcomes Yes 67 (47.90) 43 (15.40) 110 (26.19)
No 73 (52.10) 237 (84.60) 310 (73.81)
Low birth weight Yes 44 (31.40) 20 (7.10) 64 (15.24)
No 96 (68.60) 260 (92.90) 356 (84.76)
Intrauterine growth restriction Yes 13 (9.30) 2 (0.70) 15 (3.57)
No 127 (90.70) 278 (99.30) 405 (96.43)
Preterm birth Yes 42 (30.00) 17 (6.10) 59 (14.05)
No 98 (70.00) 263 (93.90) 361 (85.95)
Perinatal asphyxia Yes 26 (18.60) 16 (5.70) 42 (10)
No 114 (81.40) 264 (94.30) 378 (90)
Perinatal death Yes 23 (16.40) 8 (2.90) 31 (7.38)
No 117 (83.60) 272 (97.10) 389 (92.62)
APGAR score at 5th min <7 17 (14.40) 16 (5.80) 33 (7.86)
≥7 101 (85.60) 259 (94.20) 360 (85.71)